🇺🇸 FDA
Patent

US 9486414

Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K38/16A61K38/26

Quick answer

US patent 9486414 (Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/16, A61K38/26, A61K45/00, A61K45/06